Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Antiviral Res. 2019 Apr 7;167:25–34. doi: 10.1016/j.antiviral.2019.04.004

Table 4.

Summary of point mutations and amino acid changes in VEEV TC83 that emerged at various concentrations of BDGR-4

Nucleotide
Change
Amino Acid
Change
Gene Replicate 50 nM 100 nM 200 nM 400 nM 800 nM 1600 nM 3200 nM
G3033A E452K nsP2 R1 - - - - - - 21.4
R1 - - - 30.51 31.43 64.53 73.86
G5414A A461A nsP3 R2 - - 7.15 27.91 27.26 45.33 56.89
R3 - - 2.63 15.85 21.07 35.91 42.91
R1 - - 3.34 31.17 37.73 62.04 72.66
A5962T Y87F nsP4 R2 - - 8.37 26.95 - 45.58 62.36
R3 - - 2.95 19.91 26.23 38.7 53.9
C6330A Q210K nsP4 R2 - - - - - - 10.07
R1 - - - - - 66.8 79.01
A6331G Q210R nsP4 R2 - - - - - - 67.65
R3 - - - - - - 61.86
R1 - - 1.96 21.62 23.81 17.14 7.58
A6332T Q210H nsP4 R2 - - - 27.89 - - -
R3 - - 2.77 19.8 26.01 - -
A6341T E213D nsP4 R2 - - - 10.74 - 4.21 -
R3 - - 0.65 4.34 4.06 1.67 -
R1 - - 2.52 28.32 37.32 57.49 66.97
G6617A R305R nsP4 R2 - - 5.66 19.26 23.88 36.21 50.47
R3 - - 1.87 15.21 22.36 33.4 48.06
G10639A L213L E1 R2 - - 1.53 - - - 12.43
R3 - - - - 5.97 10.71 -